LIGABUE, Alessio
 Distribuzione geografica
Continente #
NA - Nord America 1.621
EU - Europa 699
AS - Asia 189
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
AF - Africa 1
Totale 2.514
Nazione #
US - Stati Uniti d'America 1.615
GB - Regno Unito 255
DE - Germania 92
SE - Svezia 74
CN - Cina 73
FR - Francia 65
PL - Polonia 64
SG - Singapore 61
IT - Italia 46
UA - Ucraina 35
FI - Finlandia 23
HK - Hong Kong 23
TR - Turchia 14
BG - Bulgaria 13
RU - Federazione Russa 13
BE - Belgio 8
CA - Canada 6
IE - Irlanda 5
IN - India 4
IR - Iran 4
LT - Lituania 4
VN - Vietnam 4
ID - Indonesia 3
MY - Malesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
EU - Europa 1
JP - Giappone 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RO - Romania 1
TZ - Tanzania 1
Totale 2.514
Città #
Fairfield 246
Southend 211
Woodbridge 150
Ashburn 140
Chandler 138
Houston 105
Cambridge 86
Ann Arbor 83
Seattle 83
Wilmington 79
Jacksonville 68
Santa Clara 68
Kraków 64
Nyköping 52
Dearborn 48
Frankfurt am Main 40
Singapore 37
Modena 32
Hong Kong 23
Fremont 18
New York 18
San Diego 18
Beijing 15
Princeton 14
Grafing 13
Sofia 13
Eugene 12
Helsinki 12
Des Moines 8
San Mateo 8
Brussels 7
London 7
Redwood City 7
Izmir 6
Shanghai 6
Boardman 5
Dublin 5
Toronto 5
Bremen 4
Dong Ket 4
Falls Church 4
Detroit 3
Hefei 3
Jakarta 3
Los Angeles 3
Norwalk 3
Phoenix 3
Saint Petersburg 3
Auburn Hills 2
Casagiove 2
Hounslow 2
Indiana 2
Kilburn 2
Milan 2
Monmouth Junction 2
Moscow 2
Munich 2
Nanjing 2
Amsterdam 1
Ardabil 1
Auckland 1
Augusta 1
Baotou 1
Borås 1
Chiswick 1
Clearwater 1
Dalian 1
Dar es Salaam 1
Dongguan 1
Falkenstein 1
Filottrano 1
Gatchina 1
Hangzhou 1
Hanover 1
Harbin 1
Heze 1
Irving 1
Kish 1
Kunming 1
Louvain 1
Misterbianco 1
Mountain View 1
Nanchang 1
Nürnberg 1
Ottawa 1
Parma 1
Sacramento 1
Serra 1
Shiraz 1
Southwark 1
St Petersburg 1
Taiyuan 1
Tokyo 1
Verona 1
Totale 2.039
Nome #
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 286
Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells. 240
Translational repression of thymidylate synthase by targeting its mRNA 235
Spermidine/spermine N1-acetyltransferase transient over-expression restores sensitivity of resistant human ovarian cancer cells to N1,N12-bis(ethyl)spermine and to cisplatin 234
Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and-resistant human ovarian cancer cells 222
Spermidine/spermine N1-acetyltranferasemodulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistanthuman ovarian cancer cell lines 218
Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells 205
Ligand-Based Virtual Screening and ADME-Tox Guided Approach to Identify Triazolo-quinoxalines as Folate Cycle Inhibitors. 184
Transcriptional activation and cell cycle block are the keys for 5-fluorouracil induced up-regulation of human thymidylate synthase expression 173
Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells 162
Collateral sensitivity to novel folate cycle inhibitors enhances cisplatin effectiveness against human ovarian cancer cells. 144
SSAT modulation by putative regulators of folate cycle enzymes expression in cisplatin-sensitive and –resistant human ovarian cancer cell lines. 131
Erratum: Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 34 (E542-E549) DOI: 10.1073/pnas.1104829108) 113
Totale 2.547
Categoria #
all - tutte 12.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020391 0 0 0 0 70 62 78 59 55 17 20 30
2020/2021458 37 22 48 55 51 34 22 59 14 63 29 24
2021/2022304 8 27 31 5 17 34 14 8 32 22 66 40
2022/2023305 31 44 22 41 34 48 2 37 32 1 5 8
2023/2024206 4 10 14 11 79 31 10 13 0 3 19 12
2024/2025154 20 13 17 35 69 0 0 0 0 0 0 0
Totale 2.547